Basit öğe kaydını göster

A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)

dc.contributor.authorKARAAĞAÇ AKYOL, TÜLAY
dc.contributor.authorKayikcioglu, Meral
dc.contributor.authorTokgozoglu, Lale
dc.contributor.authorYILMAZ, MEHMET
dc.contributor.authorKAYNAR, LEYLAGÜL
dc.contributor.authorGokce, Cumali
dc.contributor.authorTemizhan, Ahmet
dc.contributor.authorÖZCEBE, OSMAN İLHAMİ
dc.contributor.authorOkutan, Harika
dc.contributor.authorSag, Saim
dc.contributor.authorGul, Ozen Oz
dc.contributor.authorSalcioglu, Zafer
dc.contributor.authorYenercag, Mustafa
dc.contributor.authorAltunkeser, Bulent B.
dc.contributor.authorKUKU, İRFAN
dc.contributor.authorYasar, Hamiyet Yilmaz
dc.contributor.authorKurtoglu, Erdal
dc.contributor.authorKose, Melis Demir
dc.contributor.authorDemircioglu, Sinan
dc.contributor.authorPEKKOLAY, ZAFER
dc.contributor.authorİLHAN, OSMAN
dc.contributor.authorDurmus, Rana Berru
dc.contributor.authorAktan, Melih
dc.date.accessioned2021-03-04T12:47:41Z
dc.date.available2021-03-04T12:47:41Z
dc.identifier.citationKayikcioglu M., Tokgozoglu L., YILMAZ M., KAYNAR L., Aktan M., Durmus R. B. , Gokce C., Temizhan A., ÖZCEBE O. İ. , KARAAĞAÇ AKYOL T., et al., "A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)", ATHEROSCLEROSIS, cilt.270, ss.42-48, 2018
dc.identifier.issn0021-9150
dc.identifier.otherav_79112c8f-2764-4b8d-a13d-7ece014083df
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/83017
dc.identifier.urihttps://doi.org/10.1016/j.atherosclerosis.2018.01.034
dc.description.abstractBackground and aims: Homozygous familial hypercholesterolemia (HoFH) is a genetic condition characterized by lethally high levels of low-density lipoprotein cholesterol (LDL-C) from birth, and requires rapid and aggressive intervention to prevent death due to coronary heart disease and/or atherosclerosis. Where available, lipoprotein apheresis (LA) is the mainstay of treatment to promote survival.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectCARDIAC ve CARDIOVASCULAR SİSTEMLER
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectPERİFERAL VASKÜLER HASTALIĞI
dc.subjectTıp
dc.subjectDahili Tıp Bilimleri
dc.subjectKardiyoloji
dc.titleA nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)
dc.typeMakale
dc.relation.journalATHEROSCLEROSIS
dc.contributor.departmentEge Üniversitesi , ,
dc.identifier.volume270
dc.identifier.startpage42
dc.identifier.endpage48
dc.contributor.firstauthorID252224


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster